Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Primary Metabolic Pathways Beta-3-Adrenergic Receptor Modulation Research in obese mice demonstrated that AOD-9604 increases expression of beta-3-adrenergic receptor RNA in adipose tissue, upregulating levels from those seen in obese animals to levels comparable with lean controls
Dosage: 0.25 to 0.5 mg daily Administration: Subcutaneous injection 1 to 2 inches from lateral epicondyle Frequency: Once daily, some split into twice daily Duration: 4 to 8 weeks for acute injuries, 8 to 12 weeks for chronic Timing: Evening injection may align with natural repair cycles during sleep Starting Conservative Beginning with lower doses and gradually increasing allows you to assess your response while minimizing any potential issues
Following the two week period, researchers may continue administering a maintenance dose of 1mg/daily, if necessary to achieve full or near-full recovery among test subjects
9, Sept
I have been coming to iThriveMD ever since they opened up and I am obsessed
US$ 22.81
US$ 21.13
US$ 28.87
US$ 27.10
US$ 27.05
US$ 20.22
US$ 27.47
US$ 25.15
